New inhibitors of p38 kinase

Expert Opinion on Therapeutic Patents

Volumn 10, Issue 1, 2000, Pages 25-37

  Boehm, J C ^a   Adams, J L ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Cytokine biosynthesis inhibitor; Cytokine mediated diseases; IL 1; Inflammation; p38 kinase inhibitor; p38 MAP kinase (p38 ); TNF

Indexed keywords

2 (4 FLUOROPHENYL) 5 (4 METHYLSULFINYLPHENYL) 3 (4 PYRIDYL)PYRROLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 5 (2 AMINO 4 PYRIMIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; 5 (4 PYRIDINYL) 4 (4 FLUOROPHENYL) 1 (4 PIPERIDINYL)IMIDAZOLE; CYTOKINE; N [5 (3 DIMETHYLAMINOBENZAMIDO) 2 METHYLPHENYL] 4 HYDROXYBENZAMIDE; PROTEIN KINASE; PROTEIN KINASE INHIBITOR; RJW 68354; SB 216995; SB 218655; SU 4984; UNCLASSIFIED DRUG;

ATOPIC DERMATITIS; CONTACT DERMATITIS; CYTOKINE PRODUCTION; DRUG BINDING; DRUG STRUCTURE; DRUG TARGETING; HUMAN; INFLAMMATION; MUTAGENESIS; NONHUMAN; PATENT; PSORIASIS; REVIEW; X RAY CRYSTALLOGRAPHY;

EID: 0033989553     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.10.1.25     Document Type: Review

References (48)